Jan 17, 2013 6:37 AM PST
|
|
NasdaqGM: VRML Stock Quote
| Last Trade: | 3.08 | Day's Range: | 3.02 - 3.13 | |
| Trade Time: | 3:59pm | 52wk Range: | 1.03 - 2.79 | |
| Change: | 0.00 (0.00%) | Volume: | 220,470 | |
| Prev Close: | 3.08 | Avg Vol (3m): | 58,531 | |
| Open: | 3.06 | Market Cap: | 46.9M | |
| Bid: | 2.07 x 2 | P/E (ttm): | N/A | |
| Ask: | 3.12 x 10 | EPS (ttm): | -0.53 | |
| 1y Target Est: | N/A | Div & Yield: | 0.00 (N/A) |
NasdaqGM: VRML Overview - Company Website
Vermillion, Inc. (Vermillion) is engaged in the discovery, development and commercialization of diagnostic tests that help physicians diagnose, treat and improve outcomes for patients. The Companys tests are intended to help guide decisions regarding patient treatment, which include decisions to refer patients to specialists, to perform additional testing, or to assist in the selection of therapy. It combines multiple biomarkers into a single, reportable index score. It concentrates development of diagnostic tests in the fields of oncology, hematology, cardiology and womens health, with the initial focus on ovarian cancer. The Company focuses to address clinical questions related to early disease detection, treatment response, monitoring of disease progression, prognosis and others through collaborations.
Do you know of another great research resource for VRML that belongs here? Please let us know and provide the URL.
